This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nilsen, B. M. Articles by Helland, D. E. Search for Related Content PubMed PubMed Citation Articles by Nilsen, B. M. Articles by Helland, D. E.

 Previous Article  |  Next Article 

J. Virol., Mar 1996, 1580-1587, Vol 70, No. 3
Copyright © 1996, American Society for Microbiology

Monoclonal antibodies against human immunodeficiency virus type 1 integrase: epitope mapping and differential effects on integrase activities in vitro

BM Nilsen, IR Haugan, K Berg, L Olsen, PO Brown and DE Helland
Laboratory of Biotechnology, University of Bergen, Norway.

Human immunodeficiency virus type 1 (HIV-1) integrase (IN) catalyzes the integration of viral DNA into the host chromosome, an essential step in retroviral replication. As a tool to study the structure and function of this enzyme, monoclonal antibodies (MAbs) against HIV-1 IN were produced. Epitope mapping demonstrated that the 17 MAbs obtained could be divided into seven different groups, and the selection of MAbs representing these groups were tested for their effect on in vitro activities of IN. Four groups of MAbs recognized epitopes within the region of amino acids (aa) 1 to 16, 17 to 38, or 42 to 55 in and around the conserved HHCC motif near the N terminus of IN. MAbs binding to these epitopes inhibited end processing and DNA joining and either stimulated or had little effect on disintegration and reintegration activities of IN. Two MAbs binding to epitopes within the region of aa 56 to 102 in the central core or aa 186 to 250 in the C-terminal half of the protein showed only minor effects on the in vitro activities of IN. Three Mabs which recognized on epitope within the region of aa262 to 271 of HIV-1 IN cross-reacted with HIV-2 IN. MAbs binding to this epitope clearly inhibited end processing and DNA joining and stimulated or had little effect on disintegration. In contrast to the N-terminal- specific MAbs, these C-terminal-specific MAbs abolished reintegration activity of IN.

This article has been cited by other articles:

• Wapling, J., Moore, K. L., Sonza, S., Mak, J., Tachedjian, G. (2005). Mutations That Abrogate Human Immunodeficiency Virus Type 1 Reverse Transcriptase Dimerization Affect Maturation of the Reverse Transcriptase Heterodimer. J. Virol. 79: 10247-10257 [Abstract] [Full Text]  
• Lin, C.-W., Engelman, A. (2003). The Barrier-to-Autointegration Factor Is a Component of Functional Human Immunodeficiency Virus Type 1 Preintegration Complexes. J. Virol. 77: 5030-5036 [Abstract] [Full Text]  
• Mulder, L. C. F., Chakrabarti, L. A., Muesing, M. A. (2002). Interaction of HIV-1 Integrase with DNA Repair Protein hRad18. J. Biol. Chem. 277: 27489-27493 [Abstract] [Full Text]  
• Legastelois, I., Desgranges, C. (2000). Design and Intracellular Activity of a Human Single-Chain Antibody to Human Immunodeficiency Virus Type 1 Conserved gp41 Epitope. J. Virol. 74: 5712-5715 [Abstract] [Full Text]  
• Chen, H., Wei, S.-Q., Engelman, A. (1999). Multiple Integrase Functions Are Required to Form the Native Structure of the Human Immunodeficiency Virus Type I Intasome. J. Biol. Chem. 274: 17358-17364 [Abstract] [Full Text]  
• Ishikawa, T., Okui, N., Kobayashi, N., Sakuma, R., Kitamura, T., Kitamura, Y. (1999). Monoclonal Antibodies against the Minimal DNA-Binding Domain in the Carboxyl-Terminal Region of Human Immunodeficiency Virus Type 1 Integrase. J. Virol. 73: 4475-4480 [Abstract] [Full Text]